Clinical Trial: A Phase I Study of NS-079 in Healthy Participants

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669571) titled 'A Phase I Study of NS-079 in Healthy Participants' on June 16.

Brief Summary: The goal of this clinical trial is evaluate the safety, pharmacokinetics, and pharmacodynamics of NS-079 with its main metabolite (NS-079-M1) in healthy participants. The main questions it aims to answer are:

* Is NS-079 safe and tolerable in heathy participants under tested dosing regimen?

* What is the pharmacokinectic profile of NS-079 in healthy participants under tested dosing regimen and the effect of paroxetine? Researchers will compare NS-079 to a placebo to see the safety and tolerability when use NS-079.

Study Start Date: June, 2026

Study Typ...